The financial implications of cancer care are profound and rapidly rising.The introduction of novel cancer drugs undoubtedly enhances patient outcomes, but it concurrently propels the overall cost of care to unprecedented levels. While the value of human lives is immeasurable, the financial resources available for medical expenditures are not infinite.

All of the work and costs that do not improve quality outcomes are considered “waste.” However, value is a complex and multifaceted concept, particularly in cancer care (Figure 1), that is poorly represented by a single number of any kind.

When we talk about robotic assisted surgery, first, the oncological quality of the operation must be maintained or improved compared to that of the conventional open approach. Additionally, MIS particularly with robotic surgery platform should achieve outcomes that align better with metrics that are highly valued by patients, such as QoL and functional recovery (i.e., return to normal life and return to work), rather than focusing on the length of hospital stay or incisions. It is crucial to acknowledge that patients' perspectives on the value of surgery vary by age and are likely influenced by financial and social situations. In essence, the benefits of robotic surgery must extend beyond merely smaller incisions

Gastrointestinal and heapto pancreatic biliary Surgeons who uses Robotically assisted Surgical devices, can be devided into five categories

One notable gap in the existing literature is the lack of data demonstrating the benefits of robotic surgery in terms of patients' QoL after surgery. While MIS surgeons believe that patients may feel “better” after MIS surgery than open surgery, this perception is not supported by robust data, leaving a significant gap in demon-strating the overall value of robotic surgery in enhancing patients' postoperative QoL.

Patient-centered healthcare, enhancing the decision-making process, and tailoring care plans to individual patient needs and preferences should be key behind the choice of surgical procedure.

Some of optimistic viewpoints like, change in reimbursement policy of insurance companies, government support, additional artificial intelligence tools in robotic platforms and more and more expertise robotic surgeons availability will lead to widespread acceptance of robotic surgery and truely will add as "VALUE" service.

Resource material : Ikoma N. What defines the “value” of robotic surgery for patients with gastrointestinal cancers? Perspectives from a U.S. Cancer Center. Ann Gastroenterol Surg. 2024;8:566–579. https://doi.org/10.1002/ags3.1279